CapsoVision, Inc. (CV)
NASDAQ
Closed
Oct 9, 2026
Day's Range
6.5452 wk Range
4.38Overview - CV - CapsoVision, Inc.
Key Statistics
Valuation
Enterprise Value
300.39M
P/E (Trailing)
‪-6.45‬
P/E (Forward)
‪-15.10‬
PEG Ratio
‪-0.12‬
Price / Sales (TTM)
‪24.17‬
Price / Book
‪23.99‬
EV / EBITDA
‪-10.15‬
Profitability
Gross Margin
‪51.35%‬
Profit Margin
‪-214.73%‬
Operating Margin
‪-208.07%‬
Return on Assets
‪-132.47%‬
Return on Equity
‪-335.06%‬
Ownership
Shares Outstanding
50.03M
Float
29.73M
Short % of Shares Outstanding
‪5.05%‬
Held by Insiders
‪30.14%‬
Held by Institutions
‪9.74%‬
Price stats
50-Day Avg
‪6.41‬
200-Day Avg
‪6.83‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CV - CapsoVision, Inc.
Peers - CV - CapsoVision, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- CVNASDAQCapsoVision, Inc.353.84MMarket Cap+31.13%52-week change-6.45P/E (Trailing)‪-214.73%‬Profit Margin
- DXCMNASDAQDexCom Inc.32.21BMarket Cap+22.26%52-week change33.74P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.29.24BMarket Cap-18.85%52-week change14.81P/E (Trailing)‪9.33%‬Profit Margin
- BRKRNASDAQBruker Corp.9.63BMarket Cap+42.35%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.44%52-week change—P/E (Trailing)—Profit Margin
- PODDNASDAQInsulet Corporation9.13BMarket Cap-136.69%52-week change24.66P/E (Trailing)‪12.29%‬Profit Margin
- LIVNNASDAQLivaNova PLC4.13BMarket Cap+29.89%52-week change22.01P/E (Trailing)‪12.81%‬Profit Margin
Profile Summary - CV - CapsoVision, Inc.
About
CapsoVision, Inc. is a commercial-stage medical technology company that develops, manufactures, and markets capsule endoscopy systems for gastrointestinal imaging. The company’s products are designed to help clinicians visualize the GI tract for diagnostic and screening purposes, with a focus on detecting…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
